These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26542655)

  • 1. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Zipes DP; Kovacs RJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2343-2349. PubMed ID: 26542655
    [No Abstract]   [Full Text] [Related]  

  • 2. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Zipes DP; Kovacs RJ;
    Circulation; 2015 Dec; 132(22):e256-61. PubMed ID: 26621642
    [No Abstract]   [Full Text] [Related]  

  • 3. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS;
    Circulation; 2015 Dec; 132(22):e267-72. PubMed ID: 26527714
    [No Abstract]   [Full Text] [Related]  

  • 4. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
    Black HR; Sica D; Ferdinand K; White WB
    J Am Coll Cardiol; 2015 Dec; 66(21):2393-2397. PubMed ID: 26542658
    [No Abstract]   [Full Text] [Related]  

  • 5. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Bonow RO; Nishimura RA; Thompson PD; Udelson JE
    J Am Coll Cardiol; 2015 Dec; 66(21):2385-2392. PubMed ID: 26542667
    [No Abstract]   [Full Text] [Related]  

  • 6. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Mitten MJ; Zipes DP; Maron BJ; Bryant WJ;
    Circulation; 2015 Dec; 132(22):e346-9. PubMed ID: 26621654
    [No Abstract]   [Full Text] [Related]  

  • 7. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement from the American Heart Association and American College of Cardiology.
    Thompson PD; Myerburg RJ; Levine BD; Udelson JE; Kovacs RJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2406-2411. PubMed ID: 26542666
    [No Abstract]   [Full Text] [Related]  

  • 8. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NAM; Cooper LT; Link MS; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2362-2371. PubMed ID: 26542657
    [No Abstract]   [Full Text] [Related]  

  • 9. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Levine BD; Washington RL; Baggish AL; Kovacs RJ; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2356-2361. PubMed ID: 26542659
    [No Abstract]   [Full Text] [Related]  

  • 10. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Van Hare GF; Ackerman MJ; Evangelista JK; Kovacs RJ; Myerburg RJ; Shafer KM; Warnes CA; Washington RL
    J Am Coll Cardiol; 2015 Dec; 66(21):2372-2384. PubMed ID: 26542660
    [No Abstract]   [Full Text] [Related]  

  • 11. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Harris KM; Thompson PD; Eichner ER; Steinberg MH
    J Am Coll Cardiol; 2015 Dec; 66(21):2444-2446. PubMed ID: 26542668
    [No Abstract]   [Full Text] [Related]  

  • 12. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Mitten MJ; Zipes DP; Maron BJ; Bryant WJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2447-2450. PubMed ID: 26542663
    [No Abstract]   [Full Text] [Related]  

  • 13. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Levine BD; Baggish AL; Kovacs RJ; Link MS; Maron MS; Mitchell JH
    J Am Coll Cardiol; 2015 Dec; 66(21):2350-2355. PubMed ID: 26542656
    [No Abstract]   [Full Text] [Related]  

  • 14. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Ackerman MJ; Zipes DP; Kovacs RJ; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2424-2428. PubMed ID: 26542662
    [No Abstract]   [Full Text] [Related]  

  • 15. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Zipes DP; Link MS; Ackerman MJ; Kovacs RJ; Myerburg RJ; Estes NAM
    J Am Coll Cardiol; 2015 Dec; 66(21):2412-2423. PubMed ID: 26542670
    [No Abstract]   [Full Text] [Related]  

  • 16. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Myerburg RJ; Estes NAM
    J Am Coll Cardiol; 2015 Dec; 66(21):2434-2438. PubMed ID: 26542665
    [No Abstract]   [Full Text] [Related]  

  • 17. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Braverman AC; Harris KM; Kovacs RJ; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2398-2405. PubMed ID: 26542664
    [No Abstract]   [Full Text] [Related]  

  • 18. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Link MS; Estes NAM; Maron BJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2439-2443. PubMed ID: 26542669
    [No Abstract]   [Full Text] [Related]  

  • 19. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Estes NAM; Kovacs RJ; Baggish AL; Myerburg RJ
    J Am Coll Cardiol; 2015 Dec; 66(21):2429-2433. PubMed ID: 26542661
    [No Abstract]   [Full Text] [Related]  

  • 20. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NA; Cooper LT; Link MS; Maron MS;
    Circulation; 2015 Dec; 132(22):e273-80. PubMed ID: 26621644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.